Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Auchenflower
Clinical trial register · Australia

Clinical Trials in Auchenflower, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca8 Amgen7 Pfizer5 Novartis Pharmaceuticals4 Queensland Centre for Gynaecological Cancer3
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Auchenflower

69 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Auchenflower, Blacktown, Clayton, Liverpool
2026-09-24
Recruiting
AstraZeneca
Phase 3
950
Auchenflower, Benowa, Hobart, Kingswood, Nedlands, Port Macquarie, Randwick, Richmond
2026-09-16
Recruiting
GlaxoSmithKline
Phase 3
684
Auchenflower
2026-09-01
Recruiting
AstraZeneca
Phase 3
915
Auchenflower, Ballarat, Clayton, Darlinghurst, Elizabeth Vale, South Brisbane, St Albans
2026-07-16
Recruiting
GlaxoSmithKline
Phase 3
450
Randwick, Auchenflower
2026-06-18
Recruiting
GlaxoSmithKline
Phase 3
600
Dubbo, Auchenflower, Herston
2026-06-04
Not yet open
Queensland Centre for Gynaecological Cancer
Phase 3
640
Newcastle, Darwin, Auchenflower, Brisbane, Buderim, Adelaide, Heidelberg, Parkville
2026-06-01
Recruiting
Incyte Corporation
Phase 1
218
Concord, St Leonards, Auchenflower, East Melbourne, Nedlands
2026-05-11
Recruiting
Inhibikase Therapeutics
Phase 3
486
Auchenflower
2026-04-23
Recruiting
Amgen
Phase 3
406
Auchenflower, Sippy Downs, Leabrook
2026-03-23
Recruiting
Pfizer
Phase 1/2
132
North Ryde, Auchenflower, Clayton
2026-03-11
Recruiting
Pfizer
Phase 1/2
224
Auchenflower, Clayton
2026-02-10
Recruiting
Insmed Incorporated
Phase 3
344
Camperdown, Kingswood, New Lambton Heights, Westmead, Auchenflower, South Brisbane
2026-01-07
Recruiting
AstraZeneca
Phase 3
1,100
Adelaide, Auchenflower, Campbelltown, Camperdown, Clayton, Cudgen, Garran, Gosford
2025-12-29
Recruiting
BeOne Medicines
Phase 1
105
Blacktown, St Leonards, Auchenflower, Malvern, Melbourne, Nedlands
2025-12-11
Recruiting
Amgen
Phase 3
750
Waratah, Auchenflower, Southport, Clayton, East Melbourne
2025-11-28
Recruiting
AbbVie
Phase 2
400
Kogarah, Sydney, Auchenflower, Adelaide, Hobart, Clayton, Geelong, Melbourne
2025-11-13
Active, closed
Pfizer
Phase 2
42
Camperdown, Auchenflower
2025-11-10
Recruiting
AllRock Bio, Inc.
Phase 2
40
Camperdown, Auchenflower
2025-10-01
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Auchenflower, Brisbane, Brookvale, Castle Hill, Clayton, Concord, Douglas, Gosford
2025-09-06
Recruiting
Amgen
Phase 3
11,000
Garran, Camperdown, Charlestown, Concord, Merewether, Orange, Wollongong, Auchenflower
2025-08-22
Recruiting
Amgen
Phase 3
12,800
Charlestown, Darlinghurst, St Leonards, Auchenflower, Herston, Milton, Woolloongabba, Bedford Park
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Garran, Liverpool, St Leonards, Auchenflower, Birtinya, Herston, Milton, Southport
2025-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Camperdown, Westmead, Auchenflower, Melbourne
2025-05-12
By invitation
Vertex Pharmaceuticals Incorporated
Phase 2
44
Auchenflower, Melbourne
2025-04-28
Recruiting
Eli Lilly and Company
Phase 3
700
Auchenflower, Birtinya, Heidelberg, Kurralta Park, North Tamworth, Perth, Shepparton, Traralgon
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
582
Adelaide, Auchenflower, Hobart, St Leonards, Sydney, Townsville
2025-03-19
Recruiting
Rigicon, Inc.
Not applicable
182
Auchenflower, Garran, Hornsby, Hurstville, Malvern, Miranda, Moorabbin
2025-01-16
Recruiting
HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
NCT06649708Advanced Solid Tumor Malignancies
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Phase 1/2
100
Blacktown, Auchenflower, Malvern
2024-12-30
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Sydney, Westmead, Auchenflower
2024-10-29
Active, closed
Pfizer
Phase 3
600
Auchenflower, Clayton, Melbourne
2024-10-21
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Darlinghurst, Gateshead, Kogarah, Lismore, Macquarie Park, North Sydney, Westmead, Auchenflower
2024-09-27
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Auchenflower, Fitzroy, Hobart
2024-09-03
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
60
Liverpool, Auchenflower, Birtinya, Melbourne
2024-06-19
Recruiting
Allogene Therapeutics
Phase 2
250
Waratah, Auchenflower, Hobart, Clayton, Fitzroy, Heidelberg, Nedlands
2024-06-18
Recruiting
Verastem, Inc.
Phase 3
270
Randwick, Auchenflower, Adelaide, Melbourne, Nedlands
2024-03-18
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
NCT06242470Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck
MacroGenics
Phase 1
250
Auchenflower, Kurralta Park, Heidelberg
2024-03-06
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
47
Auchenflower, Melbourne
2024-02-20
Recruiting
Eli Lilly and Company
Phase 3
1,264
Adelaide, Auchenflower, Ballarat Central, Birtinya, Gosford, Mackay, Melbourne, Perth
2023-12-21
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Liverpool, Waratah, Auchenflower, Benowa, East Melbourne
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Liverpool, Auchenflower, Bedford Park, Clayton, East Melbourne, Melbourne
2023-12-12
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Camperdown, St Leonards, Auchenflower, Herston, Adelaide, Hobart, Launceston, Fitzroy
2023-09-18
Recruiting
Hoffmann-La Roche
Phase 3
420
Campbelltown, Coffs Harbour, Concord, Darlinghurst, Gosford, Auchenflower, Sippy Downs, Bendigo
2023-06-07
Active, closed
Gilead Sciences
Phase 3
654
Queensland, Darlinghurst, Liverpool, St Leonards, Auchenflower, Bedford Park, Hobart, Melbourne
2023-05-08
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Camperdown, Westmead, Auchenflower, Brisbane, South Brisbane
2023-03-16
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Garran, Camperdown, Concord, Auchenflower, Sippy Downs, Woolloongabba, Adelaide, Leabrook
2023-03-09
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Gosford, Kanwal, Kogarah, Liverpool, Macquarie Park, Auchenflower, Meadowbrook, Adelaide
2023-03-01
Active, closed
Klus Pharma Inc.
Phase 2
240
Auchenflower, Bedford Park, Kogarah
2023-01-17
Active, closed
Amgen
Phase 3
7,297
Garran, Camperdown, Concord, Liverpool, Sydney, Wollongong, Auchenflower, Bundaberg
2022-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Auchenflower, Chemside, Milton, Leabrook
2022-07-08
Active, closed
Novartis Pharmaceuticals
Phase 3
95
Auchenflower, South Brisbane
2022-06-15
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Botany, New Lambton Heights, Auchenflower, Milton, Woolloongabba, Adelaide, Bedford Park, Leabrook
2021-11-23
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Albury, Campbelltown, Liverpool, Northmead, Port Macquarie, Wollstonecraft, Auchenflower, Brisbane
2021-08-27
Recruiting
HighLife SAS
Not applicable
30
Auchenflower, Perth, Sydney
2021-07-01
Active, closed
AstraZeneca
Phase 3
506
Adelaide, Auchenflower, Clayton, Heidelberg, St Leonards, Subiaco
2021-06-22
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Kogarah, Hobart, Nedlands, Perth, Auchenflower
2021-04-08
Recruiting
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Queensland Centre for Gynaecological Cancer
Phase 3
760
Camperdown, Liverpool, Auchenflower, Brisbane, Buderim, Everton Park, Herston, South Brisbane
2021-01-18
Active, closed
Amgen
Phase 3
135
Auchenflower, Adelaide, Fitzroy
2020-12-04
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Auchenflower, Blacktown, Camperdown, Heidelberg, Melbourne, Nedlands
2020-08-18
Active, closed
BeOne Medicines
Phase 3
955
Canberra, Concord, East Albury, Kogarah, St Leonards, Waratah, Westmead, Auchenflower
2020-01-16
Recruiting
HighLife SAS
Not applicable
120
Darlinghurst, Newcastle, Sydney, Auchenflower, Adelaide, Brisbane, Heidelberg, Melbourne
2019-05-28
Active, closed
Celgene
Phase 3
363
Albury, Blacktown, Concord, Kogarah, Nowra, Waratah, Wollongong, Auchenflower
2019-01-02
Active, closed
AstraZeneca
Phase 3
1,018
Auchenflower, Box Hill, Brisbane, Kogarah, Orange, Parkville, Westmead, Wollongong
2018-05-14
Active, closed
Pfizer
Phase 3
1,054
Camperdown, Darlinghurst, Port Macquarie, Auchenflower, Brisbane, Chermside, South Brisbane, Southport
2017-12-18
Active, closed
BeiGene
Phase 3
590
Concord, Cudgen, Waratah, Westmead, Auchenflower, Brisbane, Herston, Adelaide
2017-10-31
Active, closed
AstraZeneca
Phase 3
1,837
Adelaide, Auchenflower, Concord, Douglas, Gosford, Hobart, Malvern, Melbourne
2014-04-22
Active, closed
MedImmune LLC
Phase 2
571
Adelaide, Auchenflower, Box Hill, Chermside, East Bentleigh, Gosford, Heidelberg, Nedlands
2013-05-17
Active, closed
Improving the Treatment for Women With Early Stage Cancer of the Uterus
NCT01686126Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma
DrugsLevonorgestrel·Mirena·Metformin
Queensland Centre for Gynaecological Cancer
Phase 2
165
Camperdown, Auchenflower, Brisbane, Greenslopes, South Brisbane, Southport, Townsville, Adelaide
2012-12
Recruiting
Boston Scientific Corporation
Observational
4,800
Auchenflower, Broadmeadow, Claremont, Hurstville, Noosa, Waurn Ponds, Wayville
2012-11-19
Rows per page Showing 1–69 of 69
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/auchenflower

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 69 of those studies with a site in Auchenflower.

How many clinical trials are recruiting in Auchenflower?

39 of the 69 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 27 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Auchenflower), 69 studies
PhaseStudiesRecruitingShare
Phase 3452665.2%
Phase 212317.4%
Phase 1/2537.2%
Not applicable334.3%
Phase 1334.3%
Observational111.4%

Most active sponsors

Lead sponsors with the most studies (Auchenflower)
Lead sponsorStudiesRecruiting
AstraZeneca84
Amgen75
Pfizer52
Novartis Pharmaceuticals40
GlaxoSmithKline33
Queensland Centre for Gynaecological Cancer31
Regeneron Pharmaceuticals33
BeOne Medicines21
Eli Lilly and Company22
HighLife SAS22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.